Ask AI

CCO Official Conference Coverage of IAS 2025: The Latest Updates in HIV *

This program outlines important data and highlights from the 13th International AIDS Society (IAS) Conference on HIV Science.

Share

Program Content

Activities

Themes From IAS 2025
Themes From IAS 2025: Emerging Evidence, Innovations, and Global Challenges
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2025

Expires: January 10, 2026

9 Capsule Summaries

Activities

ACTG A5391 DO IT
ACTG A5391/DO-IT Trial: Switching to DOR ± TDF vs Continuing INSTI + TAF/FTC in People With Obesity and HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Expires: January 14, 2026

Ulonivirine and Islatravir
Switch to Ulonivirine + Islatravir in Adults With Virologically Suppressed HIV-1: Phase IIb Trial
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Expires: January 14, 2026

Real-world LA CAB + RPV With Viremia in OPERA
Switch to LA CAB + RPV in People With HIV and Detectable Viral Load in OPERA Cohort
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2025

Expires: January 15, 2026

TECAIN
TECAIN: Randomized Trial of Topical Trichloroacetic Acid vs Electrocautery for AIN in People With HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Expires: January 16, 2026

SaDAPT
SaDAPT: Same-Day ART for People With HIV and Presumptive TB in Lesotho and Malawi
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Expires: January 16, 2026

HBV Risk With LA ART
IMPALA Subanalysis: Risk of de novo HBV Infection in Nonimmune People With HIV Using LA CAB + RPV ART
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Expires: January 16, 2026

VOLITION
VOLITION: Interim Analysis From Phase IIIb Trial of Optional Switch to LA CAB + RPV Following ART Initiation on DTG/3TC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Expires: January 16, 2026

ODYSSEY Substudy
ODYSSEY: Predictors of First-line ART Failure in Children With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Expires: January 16, 2026

Trio
Predictors of Significant Weight Gain in People With HIV on ART in the Trio Cohort Over 3-Year Period: Retrospective Analysis
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Expires: January 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC  in partnership with the International AIDS Society  

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.